Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charu Aggarwal

Showing results (61-70 of 170) with videos related to

Pageof 17
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Improved outcomes in intermediate- and high-risk aggressive non-Hodgkin lymphoma after autologous hematopoietic stem cell transplantation substituting intravenous for oral busulfan in a busulfan, cyclophosphamide, and etoposide preparative regimenCharu Aggarwal, Sameer Gupta, William P Vaughan, et al.
Oncotarget|September 23, 2016
Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imagingXiao Chen, Yizeng Yang, Ian Berger, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smokingJoshua E Reuss, Jacob Zaemes, Nishant Gandhi, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapyCharu Aggarwal, Xingmei Wang, Anjana Ranganathan, et al.
Journal of Thoracic Disease|July 14, 2026
Safety and pathologic response of neoadjuvant pulsed electric field ablation and systemic therapy in early-stage resectable lung cancer: case seriesJanani S Reisenauer, David M DiBardino, Gerard J Criner, et al.
Cancers|December 10, 2021
Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed TomographyMichelle Hershman, Bardia Yousefi, Lacey Serletti, et al.
The Journal of Liquid Biopsy|April 13, 2026
The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testingBenjamin A Bleiberg, Dylan G Scholes, Lauren Reed-Guy, et al.
Clinical Lung Cancer|July 14, 2023
Brief Report: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimensWilliam P Tompkins, Wei-Ting Hwang, Yu-Xiao Yang, et al.
The Journal of Liquid Biopsy|June 29, 2026
Erratum to "The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing" [J. Liq. Biopsy 12 (2026) 100461]Benjamin A Bleiberg, Dylan G Scholes, Lauren Reed-Guy, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2015
A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511)Taofeek K Owonikoko, Suzanne E Dahlberg, Saad A Khan, et al.
Pageof 17

Showing results (61-70 of 170) with videos related to

Sort By:
Pageof 17
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Improved outcomes in intermediate- and high-risk aggressive non-Hodgkin lymphoma after autologous hematopoietic stem cell transplantation substituting intravenous for oral busulfan in a busulfan, cyclophosphamide, and etoposide preparative regimenCharu Aggarwal, Sameer Gupta, William P Vaughan, et al.
Oncotarget|September 23, 2016
Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imagingXiao Chen, Yizeng Yang, Ian Berger, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smokingJoshua E Reuss, Jacob Zaemes, Nishant Gandhi, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapyCharu Aggarwal, Xingmei Wang, Anjana Ranganathan, et al.
Journal of Thoracic Disease|July 14, 2026
Safety and pathologic response of neoadjuvant pulsed electric field ablation and systemic therapy in early-stage resectable lung cancer: case seriesJanani S Reisenauer, David M DiBardino, Gerard J Criner, et al.
Cancers|December 10, 2021
Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed TomographyMichelle Hershman, Bardia Yousefi, Lacey Serletti, et al.
The Journal of Liquid Biopsy|April 13, 2026
The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testingBenjamin A Bleiberg, Dylan G Scholes, Lauren Reed-Guy, et al.
Clinical Lung Cancer|July 14, 2023
Brief Report: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimensWilliam P Tompkins, Wei-Ting Hwang, Yu-Xiao Yang, et al.
The Journal of Liquid Biopsy|June 29, 2026
Erratum to "The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing" [J. Liq. Biopsy 12 (2026) 100461]Benjamin A Bleiberg, Dylan G Scholes, Lauren Reed-Guy, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2015
A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511)Taofeek K Owonikoko, Suzanne E Dahlberg, Saad A Khan, et al.
Pageof 17